Jie Sun
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jie Sun has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Duy Pham
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA
2 shared publicationsLi Jiang
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA
2 shared publicationsMark H. Kaplan
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA
2 shared publicationsShuyu Yao
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA
2 shared publicationsAlexander L. Dent
Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publicationB Zhou
1] Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, Indiana, USA [2] Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, Indiana, USA
1 shared publication
Latest Publications
- 3 December 2014
- Published by Elsevier in Mucosal Immunology
- Vol. 8 (4) , 746-759
Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection
- 3 December 2014
- Published by Elsevier in Mucosal Immunology
- Vol. 8 (4) , 746-759
Control of pathogenic effector T-cell activities in situ by PD-L1 expression on respiratory inflammatory dendritic cells during respiratory syncytial virus infection
- 26 March 2014
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (229)
Intelligent Vaccine Design: Evolution of a Principle
- 26 March 2014
- Published by American Association for the Advancement of Science (AAAS) in Science Translational Medicine
- Vol. 6 (229)
Intelligent Vaccine Design: Evolution of a Principle
- 1 November 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (21) , 11884-11893
Cytokine-Dependent Induction of CD4+T cells with Cytotoxic Potential during Influenza Virus Infection
Recent evidence has identified the role of granzyme B- and perforin-expressing CD4+T cells with cytotoxic potential in antiviral immunity. However, thein vivocytokine cues and downstream pathways governing the differentiation of these cells are unclear. Here, we have identified that CD4+T cells with cytotoxic potential are specifically induced at the site of infection during influenza virus infection. The development of CD4+T cells with cytotoxic potentialin vivowas dependent on the cooperation of the STAT2-dependent type I interferon signaling and the interleukin-2/interleukin-2 receptor alpha pathway for the induction of the transcription factors T-bet and Blimp-1. We showed that Blimp-1 promoted the binding of T-bet to the promoters of cytolytic genes in CD4+T cells and was required for the cytolytic function of thein vitro- andin vivo-generated CD4+T cells with cytotoxic potential. Thus, our data define the molecular basis of regulation of thein vivodevelopment of this functionally cytotoxic Th subset during acute respiratory virus infection. The potential implications for the functions of these cells are discussed.
- 1 November 2013
- Published by American Society for Microbiology in Journal of Virology
- Vol. 87 (21) , 11884-11893
Cytokine-Dependent Induction of CD4+T cells with Cytotoxic Potential during Influenza Virus Infection
Recent evidence has identified the role of granzyme B- and perforin-expressing CD4+T cells with cytotoxic potential in antiviral immunity. However, thein vivocytokine cues and downstream pathways governing the differentiation of these cells are unclear. Here, we have identified that CD4+T cells with cytotoxic potential are specifically induced at the site of infection during influenza virus infection. The development of CD4+T cells with cytotoxic potentialin vivowas dependent on the cooperation of the STAT2-dependent type I interferon signaling and the interleukin-2/interleukin-2 receptor alpha pathway for the induction of the transcription factors T-bet and Blimp-1. We showed that Blimp-1 promoted the binding of T-bet to the promoters of cytolytic genes in CD4+T cells and was required for the cytolytic function of thein vitro- andin vivo-generated CD4+T cells with cytotoxic potential. Thus, our data define the molecular basis of regulation of thein vivodevelopment of this functionally cytotoxic Th subset during acute respiratory virus infection. The potential implications for the functions of these cells are discussed.
- 1 August 2013
- Published by Elsevier in Current Opinion in Virology
- Vol. 3 (4) , 425-429
Role of T cell immunity in recovery from influenza virus infection
- 1 August 2013
- Published by Elsevier in Current Opinion in Virology
- Vol. 3 (4) , 425-429
Role of T cell immunity in recovery from influenza virus infection
- 9 March 2012
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 12 (4) , 295-305
Regulating the adaptive immune response to respiratory virus infection
The respiratory tract is a major portal of entry for viruses into the body. Infection of the respiratory tract can, if severe, induce life-threatening damage to the lungs. Various strategies to control virus replication and to limit immune-mediated inflammation and tissue injury have evolved in the respiratory tract. Multiple innate immune cell types, particularly dendritic cells (DCs), within the pulmonary interstitium and between airway epithelial cells are strategically poised to recognize and sample airway particulates, such as viruses. In response to respiratory virus infection, several distinct DC subsets are stimulated to migrate from the site of infection in the lungs to the draining lymph nodes. Here, these migrant DCs have a crucial role in initiating the antivirus adaptive immune response to the invading viruses. After entering the infected lungs, effector T cells that were generated in the lymph nodes undergo further modifications that are shaped by the inflammatory milieu. Co-stimulatory receptor–ligand interactions between effector T cells and various cell types presenting viral antigens in the infected lungs modulate the host adaptive immune response in situ. Effector T cells that produce pro-inflammatory mediators are also the major producers of regulatory (anti-inflammatory) cytokines, providing a fine-tuning mechanism of self-control by effector T cells responding to viruses in the inflamed tissue. The immune mechanisms that control virus replication and/or excessive inflammation in the virus-infected lungs can also predispose the individual recovering from a virus infection to bacterial superinfection. Therapeutic strategies should consider balancing the need to inhibit virus replication and excessive inflammation with the need to optimize the antibacterial functions of innate immune phagocytes, which are crucial for clearing the bacteria from the lungs.
- 9 March 2012
- Published by Springer Nature in Nature Reviews Immunology
- Vol. 12 (4) , 295-305
Regulating the adaptive immune response to respiratory virus infection
The respiratory tract is a major portal of entry for viruses into the body. Infection of the respiratory tract can, if severe, induce life-threatening damage to the lungs. Various strategies to control virus replication and to limit immune-mediated inflammation and tissue injury have evolved in the respiratory tract. Multiple innate immune cell types, particularly dendritic cells (DCs), within the pulmonary interstitium and between airway epithelial cells are strategically poised to recognize and sample airway particulates, such as viruses. In response to respiratory virus infection, several distinct DC subsets are stimulated to migrate from the site of infection in the lungs to the draining lymph nodes. Here, these migrant DCs have a crucial role in initiating the antivirus adaptive immune response to the invading viruses. After entering the infected lungs, effector T cells that were generated in the lymph nodes undergo further modifications that are shaped by the inflammatory milieu. Co-stimulatory receptor–ligand interactions between effector T cells and various cell types presenting viral antigens in the infected lungs modulate the host adaptive immune response in situ. Effector T cells that produce pro-inflammatory mediators are also the major producers of regulatory (anti-inflammatory) cytokines, providing a fine-tuning mechanism of self-control by effector T cells responding to viruses in the inflamed tissue. The immune mechanisms that control virus replication and/or excessive inflammation in the virus-infected lungs can also predispose the individual recovering from a virus infection to bacterial superinfection. Therapeutic strategies should consider balancing the need to inhibit virus replication and excessive inflammation with the need to optimize the antibacterial functions of innate immune phagocytes, which are crucial for clearing the bacteria from the lungs.